Atlas Trials

A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Clinical trial NCT00430235 · COMPLETED

Trial details

NCT number
NCT00430235
Sponsor
British Columbia Cancer Agency
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the Prostate
Start date
2007-03-01
Primary completion
2010-08-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.